FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAU

Awarded to BIO X CELL, LLC

PIID 75N91021P00613US · USAspendingBiotechnology & Pharmaceuticals
$15.2K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$15,200sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateJul 12, 2021
Company legal name
BIO X CELL, LLC
UEI / CAGE
RCAAGKSC77R3 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Biotechnology & Pharmaceuticals
NAICS
325414
PSC
6505
Performance period
Not reported — Not reported
Recipient address
10 TECHNOLOGY DR STE 2 B, WEST LEBANON, GRAFTON, NH, 03784
Place of performance
WEST LEBANON, GRAFTON, NH, 03784
Source last modified
Nov 3, 2026

Description

PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAUSE THE HYBRIDOMA IS ALREADY ESTABLISHED AND IT IS A SIMPLE LABORATORY

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAU

    US · usaspendingSource ↗
  2. Value increased

    PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAU

    US · usaspending$15.2KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jul 12, 20210Not reported$15,200.00Not reportedNot reportedPURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAUSE THE HYBRIDOMA IS ALREADY ESTABLISHED AND IT IS A SIMPLE LABORATORYUSAspending ↗
BIO X CELL, LLC: PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSL — Government contract | FirmQuarry